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Studies of ferriheme cyclooxygenase, using two different assay systems, show that a 
variety of peroxides can trigger a rapid acceleration of cyclooxygenase activity to produce 
prostaglandins. Lipid hydroperoxides formed by lipoxygenase were the most potent activa- 
tors tested, followed by prostaglandin Gz, which was slightly less potent. Peroxides non- 
specifically generated during arachidonate autoxidation were as potent as the enzymatically 
formed lipid peroxides. These findings have important implications for cell function since any 
process which generates peroxides may activate the cyclooxygenase. Thus the balance 
between formation and removal of cellular lipid peroxides sets a peroxide tone that can 
regulate the rate of prostaglandin formation in cells. 
Fatty acid oxygenation catalyzed by 
cyclooxygenase is the initial, rate-limiting 
step in the conversion of free fatty acid to 
prostaglandins, thromboxanes, and prosta- 
cyclin. The appearance of these potent 
physiological agents appears to be strictly 
regulated since they occur at much lower 
levels in vivo than predicted from in vitro 
assays of total biosynthetic capacity (1, 2). 
Inhibition of cyclooxygenase by glutathione 
peroxidase (3, 4) provided the initial evi- 
dence that cyclooxygenase catalysis requires 
some peroxide which apparently could be 
generated by cyclooxygenase itself (5). 
Recently the cyclooxygenase product, 
PGG, (but not PGH,),3 has been charac- 
terized as the cyclooxygenase-produced 
activating agent (6). A low level of activating 
peroxide (estimated at 0.1 pM for the crude 
enzyme) is continuously required during 
catalysis, and a mechanism was proposed 
involving a saturable activator site on the 
enzyme (7). Since preliminary experiments 
suggested that peroxides other than PGG, 
may activate, a comparative study of hydro- 
peroxides and peroxides was made to dis- 
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cover the range of compounds capable of 
regulating prostaglandin biosynthesis. 
MATERIALS AND METHODS 
Purified cyclooxygenase was obtained as previously 
described (8, 9) and excess heme was removed by 
chromatography on diethylaminoethyl cellulose at 
pH 7.0 in 20% glycerol, 1.0 mM phenol, and 0.02 M 
potassium phosphate. Using ovine vesicular glands 
provided by the Upjohn Company, Kalamazoo, Michi- 
gan, crude acetone powder preparations of cyclo- 
oxygenase were prepared as previously described 
(10) and activated by treatment with 0.67 mM phenol 
for 30 min at 25°C (4). Unsaturated fatty acids were 
purchased from Nuchek Prep, Elysian, Minnesota, 
and arachidonic acid was purchased from Anspec 
Company, Ann Arbor, Michigan. Sodium diethyl- 
dithiocarbamate and soybean lipoxygenase were 
from Sigma Chemical Company, St. Louis, Missouri, 
and 5,5’-dithiobis(2nitrobenzoic acid), cumene hydro- 
peroxide, and t-butyl hydroperoxide were from Al- 
drich, Milwaukee, Wisconsin. The endoperoxide 
PGG, was kindly supplied by G. Graff, University 
of Minnesota. 
Oxygenation was monitored polarigraphically as 
described previously (11) with a constant temperature 
of 30 * O.l”C maintained with a Lauda K-2/R water 
bath (Brinkman Instruments). Instantaneous velocities 
were obtained directly with the help of an electronic 
differentiator (12), and for very fast reactions, the 
chart recorder was run at top speed (10 cm!min). 
Lipid hydroperoxides were generated by incubation 
of aqueous suspensions of the fatty acids with soybean 
lipoxygenase, and oxygen consumption during the 
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reaction was monitored to determine the extent of 
oxygenation of the substrate. Reaction mixtures were 
extracted three times with diethyl ether (5), and the 
lipid extracts dissolved in pentane or acetone. After 
suspending aliquots of the organic extract in 0.1 M 
Tris-chloride at pH 8.0-8.5, the concentration of 
lipid peroxide was determined using the thionitro- 
benzoate anion reduction assay described previously 
(13). The PGG, solutions (stored in ethyl acetate at 
-70°C) were dried under nitrogen in small aliquots, 
made aqueous in 0.1 M Tris-chloride (pH 8.5), and 
used immediately (within 1 min). To measure lipid 
peroxide formed during autoxidation of 14 mM arachi- 
donate, the calorimetric assay was modified by adding 
0.1% Tween 40 to reduce turbidity, and the thionitro- 
benzoate anion was measured at 460 nm, using an 
extinction coefficient of 3060 Mm' cm-‘. 
Extraction and identification of oxygenated products 
and the determination of the stoichiometry of oxygen 
addition to arachidonic acid were carried out as pre- 
viously described (9) using 3-min incubations of en- 
zyme and substrate. 
RESULTS 
In previous studies, demonstration of 
the requirement for peroxide was facili- 
tated by using inhibitors which either inter- 
fered with the activation step, or directly 
reduced the endogenous level of activating 
peroxide. Thus during the initial accelera- 
tive phase of the reaction, the product per- 
oxide was slow to accumulate and the lag 
Time (set) 
FIG. 1. Accelerated oxygenation rates in the pres- 
ence of lipid hydroperoxides. Oxygenation chambers 
contained 3 ml of 0.1 M glycine-NaOH (pH 9.5), 0.67 
mM phenol, and 50 pM 20~4 together with 5 mM DDC 
preincubated for 3 min. Cyclooxygenase [43 nM bound 
heme with 61 nM subunit, based on 70,000 daltons 
per subunit (28)] was added (first arrow), and after 
about 5 s, lo-15 ~1 of 0.1 M Tris-chloride, pH 3.5, 
was added (second arrow) with or without the indi- 
cated peroxide at a final concentration of 1 PM. 
Peroxide (,uM) 
1 
FIG. 2. Comparison of the effect of PGG, and lipid 
hydroperoxide on cyclooxygenase oxygenation rates. 
Using conditions described for Fig. 1, varying con- 
centrations of PGGZ (0 - 0), hydroperoxy-20:3(n-6) 
(m - n ), and hydroperoxy-20&-6) (x - x) or a 
buffer blank were added, and the reaction rates were 
determined at 4 s. For PGG, reactions, the rates were also 
determined after 12 s (0 - - - 0). 
phase allowed time for the addition of per- 
oxide which could trigger a more rapid 
accleration. For this reason, oxygenations 
by purified ferriheme cyclooxygenase were 
carried out at pH 9.5 in the presence of 
0.67 InM phenol, 50 PM 20:4, and 5 mM DDC. 
Lags were not appreciable unless peroxides 
were removed from the 20:4 by preincuba- 
tion with DDC for an optimum of 3 min. 
Using these assay conditions, maximal 
oxygenation rates were preceded by a sig- 
nificant lag phase (Fig. 1) which was elim- 
inated by the addition of hydroperoxy-20:3 
(n-6) or PGG2. The results illustrate that 
the hydroperoxy-20:3 was at least equal to, 
and apparently even more effective than, 
the PGG2. To further compare the stimula- 
tory effect of PGG, (an endoperoxide-hydro- 
peroxide) with other lipid hydroperoxides, 
several concentrations of the hydroperoxy 
derivatives of 20:3 and 20:4 were examined 
in reactions similar to those shown in Fig. 1. 
For simplicity, the reaction velocity at 4 s 
after the addition of peroxide was selected 
as a convenient parameter to describe stim- 
ulation. As shown in Fig. 2, the two straight- 
chain hydroperoxides were more effective 
than PGG, in triggering rapid oxygenation 
rates. It was not until 12 s after the addi- 
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tion of PGGz that the rate of oxygenation 
had accelerated to approximately the same 
magnitude achieved in 4 s with the other 
hydroperoxides. 
Further insight into the specificity among 
stimulator-y peroxides was obtained by 
comparing five different lipoxygenase-gen- 
erated peroxides using the lagging sys- 
tem obtained with a cyanide-inhibited, 
crude enzyme preparation as described 
in Fig. 3. In this system, both the increased 
velocities at 9 s (Fig. 3A) and the decreased 
times to maximum velocity (Fig. 3B) were 
convenient indexes for designating perox- 
ide stimulation (5). While each peroxide 
was quite active, the hydroperoxides of 
l&2(+6) and 20:5(n-3) showed slightly 
greater potencies. However, overall there 
was no apparent correlation based on the 
position or number of double bonds. 
To verify that the stimulation requires 
an intact hydroperoxide moiety, the effects 
of three different hydroperoxides and their 
corresponding hydroxy acids were com- 
pared. Using an assay system similar to 
that in Fig. 3, the hydroperoxides were 
effective activators, but the reduced com- 
pounds were ineffective (Fig. 4). 
The stimulatory effects of hydrogen per- 
oxide, t-butyl peroxide, and cumene hydro- 
peroxide were determined to be much less 
as shown in Fig. 5. The concentrations re- 
quired for half-maximal activation were 
Peroxide (&I) 
FIG. 4. Comparison of the activating effect of lipid 
hydroperoxides with that of their hydroxy acid deriv- 
atives. The velocity at 9 s (A) and time to optimum 
velocity (B) were measured, and lipid hydroperoxides 
were produced and assayed as described for Fig. 3. 
Hydroxy acids were obtained by reduction of the 
lipid peroxide (generated with lipoxygenase) with 
30 mg NaBH, before extraction with ether. Hydro- 
peroxy (solid lines) and hydroxy (dashed lines) acids 
were made from: 20:3(n-6) (0 - 0); 20:3(n-3) 
(A - A); l&3(%-3) (x - x). 
approximately 50-fold higher than those for 
the peroxides tested in Fig. 4. Also, al- 
though cumene hydroperoxide reduced the 
time needed to attain maximum velocity, 
the velocity at 9 s could not be elevated 
to the extent achieved with the other per- 
oxides. 
While performing assays for peroxide 
activators, significant peroxide contamina- 
tion of the stock solutions of the substrate 
20:4 was frequently noticed. As mentioned 
above, DDC, a reagent known to remove 
0 
0.5 1.0 1.5 2.0 0.5 1.0 1.5 2.0 
Peroxide &M) 
FIG. 3. Activation of prostaglandin cyclooxygenase by several fatty acid hydroperoxides. An aliquot 
of the lipid peroxide was added to 3.0 ml of 0.1 M Tris-chloride containing 0.67 mb! phenol, 50 PM 
20:4(n-6), and 1.5 mM NaCN in the oxygen electrode chamber. After 30 s, 0.38 mg of phenol-activated 
vesicular gland acetone powder preparation was added to initiate the reaction. Lipid peroxides from 
the following fatty acids were tested: 20:4(n-6) (@ - 0); 18:3(n-6) (x - - - x); 20:2(n-6) (0 - q ); 
20:5(n-3) (0 - 0); l&2(%-6) (A - A). 
LIPID PEROXIDES TRIGGER PROSTAGLANDIN FORMATION 
;k; , -‘;;-?:1~ 
50 100 150 200 50 100 150 200 
Peroxide (PM) 
FIG. 5. Effectiveness of hydrogen peroxide, t-butyl 
hydroperoxide, and cumene hydroperoxide as activa- 
tors of cyclooxygenase. Preparations of hydrogen 
peroxide (0 - 0), t-butyl hydroperoxide (A - - - A), 
and cumene hydroperoxide (X - x) were assayed 
for stimulatory activity as in Fig. 3. 
peroxide (9, 14), could remove these con- 
taminants within about 3 min. To directly 
demonstrate the spontaneous formation 
of stimulatory peroxides, solutions of 20:4 
were allowed to autoxidize for various times 
and then assayed for peroxide content and 
stimulatory activity. An untreated 14 mM 
20:4 solution, freshly prepared from the 
manufacturer (zero time), was contaminated 
with 0.69 InM peroxide, and the peroxide 
level increased with time to a level of 1.6 mM 
at 72 h. Figure 6 shows the simultaneous 
appearance of stimulatory activity and 
peroxide. Significantly, the peroxides from 
autoxidation were as stimulatory (at 0.25- 
0.53 FM) as the 15-hydroperoxy-20:3 and 
-20:4 tested in Fig. 2. In control experi- 
ments, 14 InM 20:4 that had been treated 
with sodium borohydride had no initially 
detectable peroxide and, with 0.2 mM butyl- 
ated hydroxy toluene present, no peroxide 
was detected during 72 h. The activation 
evidenced by the velocity at 6 s was no 
more than that of the blank solution of Tris 
buffer (2.9 pM &/min). 
Results from thin-layer chromatography 
(solvent system was diethyl ether:methanol: 
acetic acid, 90:1:2) showed that oxygenated 
products (generated as described in the 
legend to Fig. 1) con-&rated with PGFzo, 
(5%, Rf 0.06), PGE, (54%, Rf 0.13), PGD, 
(29% Rf 0.36), and PGHz (If%, Rf 0.88). 
The stoichiometry of oxygen consumed per 
arachidonic acid was 2.06. Reaction condi- 
tions as described in the legend to Fig. 3 
FIG. 6. Autoxidation of 20:4 generates stimulatory 
peroxides. Solutions of 26~4 in toluene were untreated, 
or treated with sodium borohydride and stored with 
0.2 mM butylated hydroxytoluene (BHT). Aliquots 
were evaporated under nitrogen and made aqueous 
in 0.1 M Tris-chloride, pH 8.5, and then allowed to 
autoxidize at 25°C for varying times. Then untreated 
(0, 0) and borohydride/BHT-treated (0, W) samples 
(14 mM) were analyzed for peroxide (closed symbols, 
see Materials and Methods) and lo-p1 aliquots of 
lo-fold diluted (3060-fold dilution overall) samples 
were analyzed for stimulatory activity as described 
for Fig. 1 (open symbols). The values listed for per- 
oxide concentration (y-axis) are 3000-fold lower than 
in the stock 14 mM solutions and represent the final 
concentrations in the reaction mixtures used to assay 
for stimulatory activity. 
yielded products which corn&rated with 
PGF2, (5%, R, 0.27), PGE, (43%, RI 0.39), 
PGD, (35%, Rf 0.53), and PGH,-hydroxy 
acids (17%, R, 0.6-0.8) using a solvent sys- 
tem of chloroform:methanol:acetic acid: 
water (90:9:0.5:1:0.5). The observed prod- 
uct distributions are characteristic for 
the spontaneous nonenzymic rearrangement 
of the endoperoxide (15). 
DISCUSSION 
The wide variety of peroxides which 
activate the cyclooxygenase leads to several 
consequences linking the regulation of cellu- 
lar peroxide levels to an indirect regulation 
of the production of prostaglandins by cyclo- 
oxygenase (Fig. 7). In the absence of acti- 
vating levels of autoxidized fatty acid in 
wivo, peroxidatic or catalatic processes 
which remove peroxides may have an inhib- 
itory effect by keeping the cyclooxygenase 
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FIG. 7. Indirect regulation of prostaglandin biosynthesis by factors which regulate the peroxide tone. 
in an inactive form. Inhibitory levels of 
glutathione peroxidase and its essential 
cofactor, glutathione, can be found in nor- 
mal tissues [e.g., (IS)]. In the presence 
of cosubstrates, any other peroxidase, in- 
cluding the cyclooxygenase peroxidase, 
would reduce the steady-state levels of 
peroxides. Also the weak triggering action 
of hydrogen peroxide would be prevented 
by catalase when present. This may be of 
some relevance in interpreting the reported 
inhibitory effect of catalase on platelet 
aggregation (1’7) and on microsomal cyclo- 
oxygenase (18). Besides enzymic removal 
of peroxides, agents which nonenzymically 
reduce peroxides (e.g., certain sulfhydryl 
compounds) or prevent the occurrence of 
peroxidation (antioxidants) may also con- 
tribute to a lowering of peroxide tone. 
Since the product, PGG*, is an activator, 
it appears that once the reaction is triggered 
by small amounts of any hydroperoxide, 
an accelerative production of peroxide then 
results in continued activation. This concept 
provides a new hypothesis for the role of 
mammalian lipoxygenases (19-24) which 
generate lipid peroxides (22). Interestingly, 
an impaired platelet aggregation associated 
with a defective level of platelet lipoxy- 
genase (25, 26) could be due to inadequate 
cyclooxygenase activity as a result of failure 
of the lipoxygenase to generate sufficient 
peroxide. Other processes, such as the 
stimulation of membrane NADH oxidase 
activity, could lead to the formation of stim- 
ulatory hydrogen peroxide. In fact, hydro- 
gen peroxide has been reported to stimulate 
cyclooxygenase activity in mollusks (27). 
In addition, oxidase-generated H,O, and 
03 can initiate membrane lipid oxidation 
leading to the formation of stimulatory 
levels of peroxidized lipids. The above hy- 
pothesis regarding peroxide tone suggests 
that further studies of phagocytic cells at 
inflammatory sites or during immune re- 
sponses may show that their production 
of oxidants and lipid peroxides facilitates 
local prostaglandin biosynthesis. 
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